Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Radiation Oncology · Anal Cancer

Building Your Care Team: Why Specialists Matter

At a Glance

Anal cancer care should be coordinated by radiation and medical oncologists, a colorectal surgeon, radiology and pathology specialists, and a nurse navigator. Tumor board review and complete imaging and pathology records help guide treatment decisions.

Because anal cancer is rare, its treatment requires a level of coordination that most common cancers do not. While your primary treatment will likely not involve surgery, having a team of specialists who work together from day one is highly advisable to ensure you receive care that follows established protocols [1][2].

The Core Specialists

In anal cancer, the roles of your doctors shift. Instead of a surgeon leading the way initially, you will likely work most closely with a radiation specialist and medical oncologist [3].

  • Radiation Oncologist: Often the “lead” for your daily care. They design the precise map for your radiation (ideally using IMRT) to target the cancer while protecting your healthy organs [4]. They are also responsible for managing skin and bowel side effects to help prevent treatment breaks [5].
  • Medical Oncologist: They manage your chemotherapy (typically Mitomycin C and 5-FU or Capecitabine) [4]. They monitor your blood counts and overall health to ensure your body is strong enough to tolerate the treatment [6].
  • Colorectal Surgeon: Even though they may not perform surgery initially, they are vital for your “baseline” exam, staging, and biopsies [7]. They remain on your team to help lead the monitoring period and are the experts called upon if a biopsy or salvage surgery (an APR) is needed later [8].
  • Nurse Navigator or Care Coordinator: This is your “air traffic controller.” They help schedule appointments, manage paperwork, and provide a direct line of communication when you have urgent questions about symptoms [7].

The Power of the Tumor Board

A hallmark of high-quality cancer care is the Multidisciplinary Tumor Board (MDT). This is a regular meeting where your radiation oncologist, medical oncologist, surgeon, radiologist, and pathologist sit in one room (or a virtual one) to discuss your specific case [7][9].

Because anal cancer response can be slow, having a group of experts look at your scans together ensures that “slow response” isn’t mistaken for “treatment failure” [8]. Research indicates that patients receiving specialist multidisciplinary review have better overall survival outcomes [2]. Seeking care at a high-volume center is beneficial, but treatment can also sometimes be coordinated locally with expert consultation. The key is ensuring specialist input guides your care.

Preparing for Your First Consultation

When you visit a specialist for a first or second opinion, ensuring your records are complete is vital. You can work with your medical-records office or nurse navigator to coordinate this:

  • Imaging: Ensure that the electronic “DICOM” files of your MRI, PET, and CT scans have been transferred. A paper report is not enough; the radiologist at the new center will want to see the actual images [10].
  • Pathology Records: Your new team may need to request the actual glass slides (or tissue blocks) from the lab where your biopsy was performed. Specialist pathologists often re-review these to confirm the exact cell type and p16 status [11].
  • Full Medical History: Include a list of all medications, prior radiation, kidney function status, and any history of immune-related conditions (such as HIV), as these can influence how your body handles chemotherapy [12].

Additionally, ask questions about practical matters such as transportation, financial assistance, or speaking with a social worker. Ensuring these details are handled early will support you through the weeks of therapy.

Common questions in this guide

Which specialists are usually part of an anal cancer care team?
An anal cancer team commonly includes a radiation oncologist, medical oncologist, and colorectal surgeon. Radiologists and pathologists review scans and biopsy tissue, while a nurse navigator or care coordinator helps organize communication and appointments.
What is an anal cancer tumor board, and why does it matter?
A multidisciplinary tumor board is a meeting where radiation and medical oncologists, a colorectal surgeon, radiologist, and pathologist review a patient’s case together. Shared review can help the team interpret a slow response accurately and coordinate next steps.
What should I send for an anal cancer second opinion?
Send the actual digital image files from MRI, PET, and CT scans, not only the written reports. Also ask for biopsy slides or tissue blocks, and provide a medication list, prior radiation history, kidney function information, and relevant immune conditions.
Who do I call about side effects during anal cancer treatment?
Before treatment starts, ask for the name and contact information of your nurse navigator or care coordinator for urgent questions. Your radiation and medical oncology teams should also explain how skin and bowel side effects will be monitored and treated.
Is surgery the first treatment for anal cancer?
Usually, the initial treatment for anal cancer is coordinated radiation and chemotherapy rather than surgery. A colorectal surgeon remains involved for evaluation and follow-up and may perform salvage surgery, including an abdominoperineal resection, if needed later.
Do I have to travel to a high-volume anal cancer center?
A high-volume center can be beneficial, but anal cancer care can sometimes be coordinated locally with consultation from experienced specialists. Ask how your local team will obtain expert input and ensure that your case receives multidisciplinary review.

Get notified when new evidence is published on anus cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Nonadherence to Multimodality Cancer Treatment Guidelines in the United States.

    Tchelebi LT, Shen B, Wang M, et al.

    Advances in radiation oncology 2022; (7(5)):100938 doi:10.1016/j.adro.2022.100938.

    PMID: 35469182
  2. 2

    Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California.

    Kumar P, Del Rosario M, Chang J, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051465.

    PMID: 36900256
  3. 3

    Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

    Benson AB, Venook AP, Al-Hawary MM, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2023; (21(6)):653-677 doi:10.6004/jnccn.2023.0030.

    PMID: 37308125
  4. 4

    Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

    Feng M, Hallemeier CL, Almada C, et al.

    Practical radiation oncology 2025; (15(4)):367-386 doi:10.1016/j.prro.2025.02.001.

    PMID: 40023252
  5. 5

    Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma.

    De B, Ludmir EB, Messick CA, et al.

    Journal of gastrointestinal oncology 2021; (12(5)):2412-2422 doi:10.21037/jgo-21-323.

    PMID: 34790402
  6. 6

    Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.

    Goodman KA, Julie D, Cercek A, et al.

    International journal of radiation oncology, biology, physics 2017; (98(5)):1087-1095 doi:10.1016/j.ijrobp.2017.03.022.

    PMID: 28721892
  7. 7

    Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

    Benson AB, Venook AP, Al-Hawary MM, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2018; (16(7)):852-871 doi:10.6004/jnccn.2018.0060.

    PMID: 30006428
  8. 8

    Management of Recurrent Anal Cancer.

    Littlejohn JB, Brister KA

    Surgical oncology clinics of North America 2025; (34(1)):91-101 doi:10.1016/j.soc.2024.07.005.

    PMID: 39547772
  9. 9

    Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).

    Moureau-Zabotto L, Vendrely V, Abramowitz L, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2017; (49(8)):831-840 doi:10.1016/j.dld.2017.05.011.

    PMID: 28610905
  10. 10

    MR Imaging of Anal Cancer.

    Young PM, Golia Pernicka JS, Jing AB, et al.

    Magnetic resonance imaging clinics of North America 2026; (34(4)):649-662 doi:10.1016/j.mric.2026.06.007.

    PMID: 42855208
  11. 11

    Squamous cell carcinoma of the anal canal.

    Morton M, Melnitchouk N, Bleday R

    Current problems in cancer 2018; (42(5)):486-492 doi:10.1016/j.currproblcancer.2018.11.001.

    PMID: 30497849
  12. 12

    The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study.

    Yoder AK, Lakomy DS, Dong Y, et al.

    BMC cancer 2021; (21(1)):776 doi:10.1186/s12885-021-08514-z.

    PMID: 34225709

This page is for informational purposes only and does not constitute medical advice. Your oncology team can recommend specialists and explain how care should be coordinated for your specific situation.